1. Home
  2. CING vs GDHG Comparison

CING vs GDHG Comparison

Compare CING & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • GDHG
  • Stock Information
  • Founded
  • CING 2012
  • GDHG 2008
  • Country
  • CING United States
  • GDHG China
  • Employees
  • CING N/A
  • GDHG N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • CING Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • CING 21.6M
  • GDHG 19.4M
  • IPO Year
  • CING 2021
  • GDHG 2023
  • Fundamental
  • Price
  • CING $3.80
  • GDHG $4.41
  • Analyst Decision
  • CING Strong Buy
  • GDHG
  • Analyst Count
  • CING 4
  • GDHG 0
  • Target Price
  • CING $33.00
  • GDHG N/A
  • AVG Volume (30 Days)
  • CING 230.9K
  • GDHG 62.2K
  • Earning Date
  • CING 11-07-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • CING N/A
  • GDHG N/A
  • EPS Growth
  • CING N/A
  • GDHG N/A
  • EPS
  • CING N/A
  • GDHG N/A
  • Revenue
  • CING N/A
  • GDHG $16,666,899.00
  • Revenue This Year
  • CING N/A
  • GDHG N/A
  • Revenue Next Year
  • CING N/A
  • GDHG N/A
  • P/E Ratio
  • CING N/A
  • GDHG N/A
  • Revenue Growth
  • CING N/A
  • GDHG N/A
  • 52 Week Low
  • CING $3.02
  • GDHG $2.40
  • 52 Week High
  • CING $6.01
  • GDHG $1,968.41
  • Technical
  • Relative Strength Index (RSI)
  • CING 47.04
  • GDHG 28.14
  • Support Level
  • CING $3.55
  • GDHG $4.36
  • Resistance Level
  • CING $4.04
  • GDHG $5.77
  • Average True Range (ATR)
  • CING 0.28
  • GDHG 0.66
  • MACD
  • CING -0.02
  • GDHG -0.33
  • Stochastic Oscillator
  • CING 29.41
  • GDHG 1.46

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: